A novel neutrophil extracellular trap-related gene signature for predicting glioblastoma prognosis

Abstract Glioblastoma (GBM) is the most common primary brain cancer, and the prognosis of traditional treatment methods is not favorable. Therefore, we aimed to identify new molecular targets and construct a risk model for GBM diagnosis and prognosis prediction on the basis of neutrophil extracellul...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao Huang, Xue-bin Yu, Yong-zhi Zhou
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-15050-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849333549051674624
author Chao Huang
Xue-bin Yu
Yong-zhi Zhou
author_facet Chao Huang
Xue-bin Yu
Yong-zhi Zhou
author_sort Chao Huang
collection DOAJ
description Abstract Glioblastoma (GBM) is the most common primary brain cancer, and the prognosis of traditional treatment methods is not favorable. Therefore, we aimed to identify new molecular targets and construct a risk model for GBM diagnosis and prognosis prediction on the basis of neutrophil extracellular trap (NET)-related genes. Gene expression and clinical data were obtained from the TCGA. We constructed a risk model based on four NET-related genes, namely, MAPK1, P2RX1, PARVB and STAT3, using univariate, LASSO and multivariate Cox analyses. The receiver operating characteristic curve analysis with the pROC package revealed that the area under the curve (AUC) values for 1-, 2- and 3-year survival were 0.73, 0.81 and 0.83, respectively. In addition, correlation analysis revealed that MAPK1 expression was negatively correlated with IL15, whereas PARVB, P2RX1 and STAT3 expression levels were positively correlated with IL15, PADI4, CXCL1 and CSF1. In vitro, overexpression of PARVB and P2RX1 STAT3 and the knockdown of MAPK1 promoted the malignant behaviors of GBM cells and activated EMT pathways. Drug sensitivity analysis revealed that STAT3 expression was positively associated with sensitivity to most drugs, whereas MAPK1, PARVB and P2RX1 expression levels were negatively correlated with most drug sensitivity. In conclusion, we identified four NET-related hub genes related to the prognosis of GBM and constructed a risk model with good performance.
format Article
id doaj-art-2d16d9f4fc644461b9c1bea5c917c829
institution Kabale University
issn 2045-2322
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-2d16d9f4fc644461b9c1bea5c917c8292025-08-20T03:45:49ZengNature PortfolioScientific Reports2045-23222025-08-0115111510.1038/s41598-025-15050-4A novel neutrophil extracellular trap-related gene signature for predicting glioblastoma prognosisChao Huang0Xue-bin Yu1Yong-zhi Zhou2Neurosurgery, Shaoxing People’s HospitalNeurosurgery, Shaoxing People’s HospitalNeurosurgery, Shaoxing People’s HospitalAbstract Glioblastoma (GBM) is the most common primary brain cancer, and the prognosis of traditional treatment methods is not favorable. Therefore, we aimed to identify new molecular targets and construct a risk model for GBM diagnosis and prognosis prediction on the basis of neutrophil extracellular trap (NET)-related genes. Gene expression and clinical data were obtained from the TCGA. We constructed a risk model based on four NET-related genes, namely, MAPK1, P2RX1, PARVB and STAT3, using univariate, LASSO and multivariate Cox analyses. The receiver operating characteristic curve analysis with the pROC package revealed that the area under the curve (AUC) values for 1-, 2- and 3-year survival were 0.73, 0.81 and 0.83, respectively. In addition, correlation analysis revealed that MAPK1 expression was negatively correlated with IL15, whereas PARVB, P2RX1 and STAT3 expression levels were positively correlated with IL15, PADI4, CXCL1 and CSF1. In vitro, overexpression of PARVB and P2RX1 STAT3 and the knockdown of MAPK1 promoted the malignant behaviors of GBM cells and activated EMT pathways. Drug sensitivity analysis revealed that STAT3 expression was positively associated with sensitivity to most drugs, whereas MAPK1, PARVB and P2RX1 expression levels were negatively correlated with most drug sensitivity. In conclusion, we identified four NET-related hub genes related to the prognosis of GBM and constructed a risk model with good performance.https://doi.org/10.1038/s41598-025-15050-4GlioblastomaNeutrophil extracellular trapsPrognosisNatural killer cellsDrug sensitivity
spellingShingle Chao Huang
Xue-bin Yu
Yong-zhi Zhou
A novel neutrophil extracellular trap-related gene signature for predicting glioblastoma prognosis
Scientific Reports
Glioblastoma
Neutrophil extracellular traps
Prognosis
Natural killer cells
Drug sensitivity
title A novel neutrophil extracellular trap-related gene signature for predicting glioblastoma prognosis
title_full A novel neutrophil extracellular trap-related gene signature for predicting glioblastoma prognosis
title_fullStr A novel neutrophil extracellular trap-related gene signature for predicting glioblastoma prognosis
title_full_unstemmed A novel neutrophil extracellular trap-related gene signature for predicting glioblastoma prognosis
title_short A novel neutrophil extracellular trap-related gene signature for predicting glioblastoma prognosis
title_sort novel neutrophil extracellular trap related gene signature for predicting glioblastoma prognosis
topic Glioblastoma
Neutrophil extracellular traps
Prognosis
Natural killer cells
Drug sensitivity
url https://doi.org/10.1038/s41598-025-15050-4
work_keys_str_mv AT chaohuang anovelneutrophilextracellulartraprelatedgenesignatureforpredictingglioblastomaprognosis
AT xuebinyu anovelneutrophilextracellulartraprelatedgenesignatureforpredictingglioblastomaprognosis
AT yongzhizhou anovelneutrophilextracellulartraprelatedgenesignatureforpredictingglioblastomaprognosis
AT chaohuang novelneutrophilextracellulartraprelatedgenesignatureforpredictingglioblastomaprognosis
AT xuebinyu novelneutrophilextracellulartraprelatedgenesignatureforpredictingglioblastomaprognosis
AT yongzhizhou novelneutrophilextracellulartraprelatedgenesignatureforpredictingglioblastomaprognosis